Ken Takanashi, Director at Satsuma Pharmaceuticals, Inc. (STSA), bought 267,074 shares at $15.00 ($3.5M) on 2019-09-17, disclosed to the SEC on 2019-09-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 33,741 | $0 | 0.0% |
| 2 | $15.00 | 233,333 | $3.5M | 100.0% |
| Total | $13.10 avg | 267,074 | $3.5M | 100% |
| Filing → |
| STSA | BUY | 2023-06-08 | $40.1M | — | Filing → |
| WVE | BUY | 2015-11-18 | $2.0M | — | Filing → |